Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

International gestational age-specific centiles for blood pressure in pregnancy from the INTERGROWTH-21st Project in 8 countries: A longitudinal cohort study.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Corporate Authors:
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science, [2004]-
    • الموضوع:
    • نبذة مختصرة :
      Background: Gestational hypertensive and acute hypotensive disorders are associated with maternal morbidity and mortality worldwide. However, physiological blood pressure changes in pregnancy are insufficiently defined. We describe blood pressure changes across healthy pregnancies from the International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st) Fetal Growth Longitudinal Study (FGLS) to produce international, gestational age-specific, smoothed centiles (third, 10th, 50th, 90th, and 97th) for blood pressure.
      Methods and Findings: Secondary analysis of a prospective, longitudinal, observational cohort study (2009 to 2016) was conducted across 8 diverse urban areas in Brazil, China, India, Italy, Kenya, Oman, the United Kingdom, and the United States of America. We enrolled healthy women at low risk of pregnancy complications. We measured blood pressure using standardised methodology and validated equipment at enrolment at <14 weeks, then every 5 ± 1 weeks until delivery. We enrolled 4,607 (35%) women of 13,108 screened. The mean maternal age was 28·4 (standard deviation [SD] 3.9) years; 97% (4,204/4,321) of women were married or living with a partner, and 68% (2,955/4,321) were nulliparous. Their mean body mass index (BMI) was 23.3 (SD 3.0) kg/m2. Systolic blood pressure was lowest at 12 weeks: Median was 111.5 (95% CI 111.3 to 111.8) mmHg, rising to a median maximum of 119.6 (95% CI 118.9 to 120.3) mmHg at 40 weeks' gestation, a difference of 8.1 (95% CI 7.4 to 8.8) mmHg. Median diastolic blood pressure decreased from 12 weeks: 69.1 (95% CI 68.9 to 69.3) mmHg to a minimum of 68.5 (95% CI 68.3 to 68.7) mmHg at 19+5 weeks' gestation, a change of -0·6 (95% CI -0.8 to -0.4) mmHg. Diastolic blood pressure subsequently increased to a maximum of 76.3 (95% CI 75.9 to 76.8) mmHg at 40 weeks' gestation. Systolic blood pressure fell by >14 mmHg or diastolic blood pressure by >11 mmHg in fewer than 10% of women at any gestational age. Fewer than 10% of women increased their systolic blood pressure by >24 mmHg or diastolic blood pressure by >18 mmHg at any gestational age. The study's main limitations were the unavailability of prepregnancy blood pressure values and inability to explore circadian effects because time of day was not recorded for the blood pressure measurements.
      Conclusions: Our findings provide international, gestational age-specific centiles and limits of acceptable change to facilitate earlier recognition of deteriorating health in pregnant women. These centiles challenge the idea of a clinically significant midpregnancy drop in blood pressure.
      Competing Interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: PW holds grants from the National Institute for Health Research; LM and AP are supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). SG is funded by an NIHR Doctoral Research Fellowship (DRF-2016-09-073). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. LM works part-time for Sensyne Health. PW worked for Sensyne Health. Both have share options in Sensyne Health; ZB is a member of the Editorial Board of PLOS Medicine; no other relationships or activities that could appear to have influenced the submitted work.
    • References:
      Obstet Gynecol. 2020 Mar;135(3):653-664. (PMID: 32028507)
      BJOG. 2013 Sep;120 Suppl 2:71-6, v. (PMID: 23679843)
      Lancet Diabetes Endocrinol. 2014 Oct;2(10):781-92. (PMID: 25009082)
      PLoS Med. 2014 Jul 08;11(7):e1001672. (PMID: 25003759)
      Food Nutr Bull. 2004 Mar;25(1 Suppl):S5-14. (PMID: 15069915)
      Hypertension. 2018 Jul;72(1):24-43. (PMID: 29899139)
      J Hypertens. 2011 Apr;29(4):763-8. (PMID: 21178781)
      J Hypertens. 2015 Jan;33(1):96-105. (PMID: 25255393)
      BJOG. 2013 Sep;120 Suppl 2:42-7, v. (PMID: 23841804)
      J Hypertens. 2014 Apr;32(4):849-56. (PMID: 24406777)
      Lancet. 2007 Oct 20;370(9596):1453-7. (PMID: 18064739)
      Resuscitation. 2019 Jan;134:147-156. (PMID: 30287355)
      Sci Rep. 2017 Jul 24;7(1):6227. (PMID: 28740155)
      BJOG. 2019 Feb;126(3):383-392. (PMID: 29782079)
      Sci Transl Med. 2015 Aug 5;7(299):299ra122. (PMID: 26246167)
      Clin Sci. 1969 Oct;37(2):395-407. (PMID: 5358998)
      Am J Hypertens. 2013 Jan;26(1):141-8. (PMID: 23382338)
      BJOG. 2013 Sep;120 Suppl 2:9-26, v. (PMID: 23678873)
      Anaesthesia. 2014 Jul;69(7):687-92. (PMID: 24801160)
      Lancet. 2014 Sep 6;384(9946):869-79. (PMID: 25209488)
      Acta Obstet Gynecol Scand. 2001 Sep;80(9):824-9. (PMID: 11531633)
      J Hypertens. 2010 Nov;28(11):2210-8. (PMID: 20724938)
      Am J Med. 1980 Jan;68(1):97-104. (PMID: 7350810)
      BMC Med. 2019 Sep 11;17(1):167. (PMID: 31506067)
    • Grant Information:
      United Kingdom DH_ Department of Health
    • الموضوع:
      Date Created: 20210427 Date Completed: 20210811 Latest Revision: 20210811
    • الموضوع:
      20240829
    • الرقم المعرف:
      PMC8112691
    • الرقم المعرف:
      10.1371/journal.pmed.1003611
    • الرقم المعرف:
      33905424